As an industry pioneer in molecular diagnostics, MEDIVEN is dedicated to developing real-time PCR (qPCR) technology to satisfy the changing needs of infectious disease detection, especially in Southeast Asia. We specialize in TaqMan probe-based PCR kits, creating high-sensitivity, high-specificity diagnostic solutions for a wide range of illnesss including respiratory pathogens like Influenza, MERS, MTBC/NTM, and COVID-19, as well as tropical diseases such as Dengue, Malaria, and Leptospirosis. In high-stakes clinical settings, our ongoing advancements in speed, sensitivity, and strain-specific targeting enable medical professionals and labs to make quicker, more accurate decisions.
- Advancements in PCR Techniques
We’ve enhanced every stage of the qPCR process for superior diagnostic performance:
Speed Improvements
Our assays feature shorter run time protocols and high-efficiency enzymes that allow faster denaturation, annealing, and extension, which significantly reduce total test time without compromising performance.
High Sensitivity
Leveraging optimized enzyme formulations and primer-probe designs, our qPCR kits achieve low limits of detection, enabling the identification of pathogens even in early or asymptomatic stages.
High-Throughput Ready
Our high-throughput assays support multiplexing of up to five targets, 96- or 384-well formats and automated workflows, which saves time, money, and sample volume in clinical and surveillance settings.
- Innovations in qPCR and Multiplexing
Our platform employs TaqMan probe-based qPCR to ensure high specificity and real-time detection of target pathogens.
Real-Time PCR (qPCR) Advantage
Our qPCR platform uses TaqMan probe-based detection to deliver high specificity and dependable pathogen identification. Tailored for qualitative diagnostics, it ensures clear positive or negative results with minimal background interference. The system is optimized for rapid cycling and allowing smooth integration into clinical and public health workflows.
Multiplex PCR Advantage
Our multiplex qPCR kits facilitate syndromic diagnosis by identifying multiple pathogens in a single reaction. This is especially helpful for tropical fevers like dengue, malaria, or leptospirosis where symptoms can overlap.
- Enhancing Reagents, QC, and Workflow Integration
Cross-Instrument Compatibility
Our reagents are optimized for consistent performance across major qPCR platforms (e.g., Bio-Rad, Applied Biosystems), delivering uniform amplification curves with minimal variability.
Built-In Quality Controls
All qPCR kits include an internal control to verify reaction validity. Many of our kits also incorporate UDG (Uracil-DNA Glycosylase) to help prevent carryover contamination and improve reliability, particularly in high-throughput workflows.
Streamlined Reagents
Ready-to-use master mixes support fast, one-step RT-qPCR workflows, minimizing pipetting steps, hands-on time, and human error.
Advancing Diagnostic Software
Our GenoAmp Viewer software is currently under development and will support automated result interpretation and reporting across all qPCR assays once completed.
- Our Unique Regional Specialization in Multiplex qPCR
Our true distinction lies in our specialized approach to developing multiplex qPCR kits specifically tailored for Southeast Asia. We don’t just offer high-performance diagnostic solutions; we ensure they are clinically relevant to the unique epidemiological landscape of the region.
For instance, our Leptospirosis kit is designed to detect strains prevalent in Southeast Asia, providing crucial accuracy where generic assays might fall short. Similarly, our malaria differentiation kit specifically includes detection for Plasmodium knowlesi, a zoonotic malaria species of significant concern in this region. This targeted approach ensures that medical professionals and public health teams in ASEAN have access to the most accurate and actionable diagnostic information, directly impacting patient care and disease surveillance efforts.
Our innovation is strategic rather than merely technical. Our assays provide timely, relevant, and reliable results by concentrating on pathogens of clinical significance, assisting public health teams and clinicians in better responding to the threats posed by infectious diseases.
